Post Vaccine Rubella During a Measles Outbreak: Clinical Case

• Autor(a) principal: Graça, Luísa
• Data de Publicação: 2021
• Outros Autores: Pereira, Sara, Duro, Raquel, Sarmento, António
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12670
• topic: Disease Outbreaks; Measles; Measles-Mumps-Rubella Vaccine; Rubella; Rubéola; Sarampo; Surtos de Doença; Vacina contra Sarampo-Parotidite-Rubéola

Rubella is a vaccine preventable infection, and congenital rubella the most feared complication of this disease. Although young adult women are at greatest risk of post-vaccine rubella, this is also the group who potentially benefits the most from vaccine protection. Since post-vaccine disease has a mild and self-limited course, the benefit clearly exceeds the risk. During a measles outbreak in the north of Portugal, a 38-year-old woman presented with cervical posterior lymphadenopathies, fever and a maculo-papular rash one week after the administration of the measles, mumps and rubella vaccine. Measles was discarded and rubella viremia was demonstrated. Symptoms of rubella are non-specific and laboratory confirmation is essential. This is particularly relevant during a measles outbreak.